Tagged Articles

painkiller 67 articles

Tennessee Chiropractor Settles Whistleblower’s Opioid Allegations

A Tennessee chiropractor who allegedly prescribed opioids with no legitimate medical purpose through his four pain clinics and then billed Medicare and Medicaid for them will pay the U.S. more than $1.45 million plus interest to settle the accusations, which were initiated by a whistleblower under the False Claims Act. The U.S. Department of Justice said that from 2011 through 2014, Lenior City chiropractor Matthew Anderson and his management company PMC LLC, which managed four now-defunct pain clinics, wrote opioid prescriptions for patients who had no legitimate need for them. The patients, many of them Medicare and Medicaid beneficiaries, had ... Read More

Painkiller recalled due to improper expiration dates on label

Sagent Pharmaceuticals has issued a nationwide recall on a painkiller. Three lots of Ketorolac Tromethamine Injection, a nonsteroidial anti-inflammatory drug, were recalled because the medications were printed with the incorrect expiration date. The labeled date is longer than the known stability of the drug. Ketorolac Tromethamine is used short-term in postoperative patients to treat moderately severe acute pain that requires analgesia in patients already using opioid painkillers. The affected lots include 30mg/mL single-dose vials with the NDC numbers 25021-701-01 and 25021-701-02. Affected lot numbers include MP5021, MP5024, and MP5025 and were distributed to hospitals, wholesalers and distributors across the country ... Read More

Anti-addiction groups call for FDA chief’s resignation amid prescription drug abuse epidemic

Frustrated by the Food and Drug Administration’s approval of potent opioid medications during a nationwide epidemic of prescription drug abuse, anti-addiction activists are calling for the resignation of the agency’s top official. More than a dozen groups have banded together and are appealing to the Obama administration to replace FDA Commissioner Dr. Margaret Hamburg, who has headed up the agency since 2009. Activists have been vocal about their disappointment with the agency for its approval of Zohydro, the only single-ingredient hydrocodone on the market. Hydrocodone is in a class of narcotics known as opioids, which are known for their euphoric effects. ... Read More

Acetaminophen as effective as placebo in treating lower back pain

The commonly used painkiller acetaminophen, the same drug in over-the-counter Tylenol, doesn’t relieve lower-back pain any better than a placebo, according to a new study published in the journal The Lancet. Medical guidelines recommend acetaminophen as a first-line treatment for acute lower back pain, however few studies have been conducted to show whether the treatment actually works. Researchers with the University of Sydney in Australia set out to put the painkiller to the test. For the study, researchers randomly assigned more than 1,600 people with sudden, or acute, lower-back pain into three groups. One group took acetaminophen tablets regularly three ... Read More

FDA approves oxycodone combination drug that resists abuse

A powerful combination opioid painkiller whose euphoric effects can be rendered inactive if the drug is tampered with has been approved by the Food and Drug Administration (FDA). The drug’s formulation aligns with the agency’s commitment to combat the misuse and abuse of opioids. “The development of opioids that are harder to abuse is needed in order to help address the public health crisis of prescription drug abuse in the U.S.,” Dr. Sharon Hertz, deputy director of the division of anesthesia, analgesia, and addiction products in the FDA’s Center for Drug Evaluation and Research, said in an news release. Targiniq ... Read More

FDA panel slated to review powerful new opioid painkiller

Just weeks after the Food and Drug Administration (FDA) refused to take the advice of medical doctors, anti-drug abuse groups, and several attorneys general to reconsider its approval of the powerful new opioid Zohydro, another drug company announced that the agency has agreed to review its investigational extended-release oral formulation of the same narcotic plus acetaminophen. Critics warned the FDA that approving another powerful opioid would only fuel an already growing epidemic of prescription drug abuse. Opioids, which include the medications morphine and oxycodone, are the most abused prescription drug in the United States. Drug company Mallinckrodt is seeking approval ... Read More

Too many children prescribed codeine despite black box warnings

At least a half million children are prescribed medications containing the potent painkiller codeine during emergency room visits each year despite warnings that the drug be used sparingly in children because it can be fatal in some circumstances, according to a study published in the journal Pediatrics. Only about 3 percent of emergency room visits involving children resulted in a codeine prescription in 2010; however, with more than 25 million ER visits for children each year, that still translates to too many children being treated with the drugs. Codeine is an opioid pain reliever used to treat mild to moderate ... Read More

Federal judge blocks Massachusetts ban of new painkiller Zohydro

Drug maker Zogenix Inc., won another battle in its war to get its controversial painkiller Zohydro on the market. This week, a Massachusetts federal judge blocked plans by Massachusetts Gov. Deval Patrick to ban prescriptions and sales of the newly approved narcotic in the state in an attempt to curb a growing trend of prescription drug abuse. Zogenix filed a lawsuit alleging the move was unconstitutional. U.S. District Judge Rya Zobel ruled that the ban conflicted with federal laws, which take precedence against state laws when the two are in conflict. The U.S. Food and Drug Administration (FDA) approved Zohydro ... Read More

Massachusetts governor’s ban of Zohydro may be unconstitutional

Massachusetts governor Deval Patrick’s banning of the controversial new painkiller Zohydro may be the first time a state has tried to block distribution of an FDA-approved drug and sets the stage for a heated constitutional debate. Last week, Gov. Patrick restricted doctors in Massachusetts from prescribing or dispensing Zohydro, the only pure hydrocodone on the market. The medication was approved by the FDA last fall and was distributed nationwide last month. Gov. Patrick banned the drug in an effort to curb a growing prescription drug abuse epidemic. In response, Zohydro’s maker, Zogenix, filed a lawsuit this week in an attempt ... Read More

Zohydro maker files lawsuit to block Massachusetts governor’s ban

Less than a week after Massachusetts governor Deval Patrick banned the sale of the controversial new potent painkiller Zohydro, the drug’s maker has filed a lawsuit aimed at blocking the governor’s request. Zogenix filed the lawsuit in U.S. District Court in Massachusetts Monday. A hearing was scheduled for Tuesday afternoon. The drug company contends that Gov. Patrick’s order to ban its potent opioid goes against the U.S. Food and Drug Administration (FDA), which approved the drug for marketing last fall. Zohydro hit the market nationwide last month. Gov. Patrick banned the drug as part of an attempt to quell a ... Read More